A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia

Adult acute lymphoblastic leukemia with a rare b3a3 type BCR/ABL1 fusion transcript

(2016) Daisuke Kurita et al.   Cancer Genetics

Next-Generation Sequencing: Targeting Targeted Therapies

(2015) J. N. McCutcheon et al.   CLINICAL CANCER RESEARCH

Chronic myeloid leukaemia

(2015) Jane F Apperley   LANCET

Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis

(2015) Cláudia M. Salgado et al.   MELANOMA RESEARCH

Cancer whole-genome sequencing: present and future

(2015) H Nakagawa et al.   ONCOGENE

Mapping of apoptin-interaction with BCR-ABL1, and development of apoptin-based targeted therapy

(2015) Jaganmohan R. Jangamreddy et al.   Oncotarget

Non-small cell lung cancer with EML4-ALKtranslocation in Chinese male never-smokers is characterized with early-onset

(2014) Yongjun Guo et al.   BMC CANCER

Novel BCR-ABL1 fusion identified by targeted next-generation sequencing in a patient with an atypical myeloproliferative neoplasm

(2014) Lori Frederick et al.   HUMAN PATHOLOGY

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

(2014) R Kihara et al.   LEUKEMIA

A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia

(2013) Sohela Shah et al.   NATURE GENETICS

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia

(2011) A. Slupianek et al.   BLOOD

Mutations and Deletions of the TP53 Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic Leukemia

(2011) Jana Hof et al.   JOURNAL OF CLINICAL ONCOLOGY

Exome sequencing as a tool for Mendelian disease gene discovery

(2011) Michael J. Bamshad et al.   NATURE REVIEWS GENETICS

BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib

(2010) D. W. Sherbenou et al.   BLOOD

TP53Mutation and Survival in Chronic Lymphocytic Leukemia

(2010) Thorsten Zenz et al.   JOURNAL OF CLINICAL ONCOLOGY

Comprehensive Characterization of a Novel Intronic Pseudo-Exon Inserted within an e14/a2 BCR-ABL Rearrangement in a Patient with Chronic Myeloid Leukemia

(2010) Nathalie Sorel et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1

(2010) M Thai et al.   LEUKEMIA

ABL Tyrosine Kinases: Evolution of Function, Regulation, and Specificity

(2010) J. Colicelli   Science Signaling

Apoptin, a tumor-selective killer

(2009) Marek Los et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

BCR/ABL rearrangement with b3a3 fusion transcript in a case of childhood acute lymphoblastic leukemia

(2009) Juwon Kim et al.   CANCER GENETICS AND CYTOGENETICS

A Rare e14a3 (b3a3) BCR-ABL Fusion Transcript in Chronic Myeloid Leukemia

(2009) Natini Jinawath et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Sequencing technologies — the next generation

(2009) Michael L. Metzker   NATURE REVIEWS GENETICS